Anavex Life Sciences (AVXL) Stock Price, Quote, News & History | Benzinga

Anavex Life Sciences Corp (AVXL) Stock Price, Quote, News & History

AVXLNASDAQ

Trade with Public

Trade with Public

$3.56

0.4514.47%

At close: Aug 25, 5:00 PM EST

$3.55

-0.01-0.28%

After Hours: 6:35 PM EST

PRO

Why Is It Moving?™:Anavex Life Sciences shares are trading higher after the company reported b...

Earnings: Q3 2026 earnings were released today before the market open

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$3.37

Close

$3.56

Volume / Avg.

2.47M / 1.16M

Day Range

$3.37 - $3.68

52 Wk Range

2.26 - 10.40

Market Cap

$329.07M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

64

Short Interest

16.2%

Days to Cover

14.43

Recent Anavex Life Sciences Corp News

Crude Oil Moves Lower; Cintas Raises FY2026 Forecast

The Dow Jones index gained over 300 points, with the S&P 500 and NASDAQ also rising. Cintas Corp posted strong earnings and raised its forecast, while Sarepta Therapeutics and Braze Inc saw significant gains.

Avi Kapoor

Dow Surges Over 300 Points; Chewy Shares Jump On Upbeat Earnings

US stocks rise with the Dow gaining over 300 points. Chewy shares jump 14%. Sarepta Therapeutics surges 29%. Oil down 2.1%, gold up 3.2%.

Avi Kapoor

Anavex Life Sciences Stock Crushed As European Alzheimer's Drug Filing Pulled After EMA Pushback

Anavex shares fall after pulling EU filing for blarcamesine in Alzheimer's; EMA feedback prompts more data work.

Vandana Singh

Anavex Life Lead Drug Targets Early Alzheimer's Cause - New Study Highlights

New study links early brain cleanup failure to Alzheimer's, supporting Anavex Life drug approach targeting disease before plaques form.

Vandana Singh

What's Going On With Anavex Life Sciences Stock On Wednesday?

Anavex Life Sciences' stock rises despite no news, up over 40% this year as investors watch Alzheimer's program updates and analyst targets.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-34.08M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

45.05M

Free Cash Flow (TTM)

-34.08M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

10.97M

Analyst Trends and Forecast

3

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$160.87M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

2.37

Earnings Yield % (TTM)

-12.54%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.31

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$131.75M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$3.37

Close

$3.56

Volume / Avg.

2.47M / 1.16M

Day Range

$3.37 - $3.68

52 Wk Range

2.26 - 10.40

Market Cap

$329.07M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

64

Short Interest

16.2%

Days to Cover

14.43

About

Sector

Health Care

Industry

Biotechnology

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data fr...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Anavex Life Sciences (AVXL) stock?

A

You can purchase shares of Anavex Life Sciences (NASDAQ:AVXL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Anavex Life Sciences (AVXL) competitors?

A

Other companies in Anavex Life Sciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Anavex Life Sciences (AVXL) stock?

A

Anavex Life Sciences has a consensus price target of $30.00.

Q

What is the current price for Anavex Life Sciences (AVXL)?

A

The stock price for Anavex Life Sciences (NASDAQ: AVXL) is $3.55 last updated August 25, 2026 at 6:35 PM EDT.

Q

Does Anavex Life Sciences (AVXL) pay a dividend?

A

There are no upcoming dividends for Anavex Life Sciences.

Q

When is Anavex Life Sciences (NASDAQ:AVXL) reporting earnings?

A

Anavex Life Sciences does not have any upcoming earnings scheduled.

Q

Is Anavex Life Sciences (AVXL) going to split?

A

There is no upcoming split for Anavex Life Sciences.

Q

What sector and industry does Anavex Life Sciences (AVXL) operate in?

A

Anavex Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.